Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Narjes

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|May 29, 2001
Hepatitis C virus protease inhibitors: current progress and future challengesC Steinkühler, U Koch, F Narjes, et al.
The Journal of Biological Chemistry|April 4, 1997
Substrate specificity of the hepatitis C virus serine protease NS3A Urbani, E Bianchi, F Narjes, et al.
Analytical Biochemistry|August 15, 1996
A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substratesM Taliani, E Bianchi, F Narjes, et al.
Journal of Virology|September 18, 2001
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor proteinM Pallaoro, A Lahm, G Biasiol, et al.
Biochemistry|February 26, 2000
Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 proteaseF Narjes, M Brunetti, S Colarusso, et al.
The Journal of Biological Chemistry|March 4, 2000
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexesS Di Marco, M Rizzi, C Volpari, et al.
The Journal of Biological Chemistry|May 16, 2000
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transferD Fattori, A Urbani, M Brunetti, et al.
The EMBO Journal|March 16, 2000
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domainG Barbato, D O Cicero, F Cordier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 6, 2006
Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymeraseC Giuliano, F Fiore, A Di Marco, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|May 29, 2001
Hepatitis C virus protease inhibitors: current progress and future challengesC Steinkühler, U Koch, F Narjes, et al.
The Journal of Biological Chemistry|April 4, 1997
Substrate specificity of the hepatitis C virus serine protease NS3A Urbani, E Bianchi, F Narjes, et al.
Analytical Biochemistry|August 15, 1996
A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substratesM Taliani, E Bianchi, F Narjes, et al.
Journal of Virology|September 18, 2001
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor proteinM Pallaoro, A Lahm, G Biasiol, et al.
Biochemistry|February 26, 2000
Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 proteaseF Narjes, M Brunetti, S Colarusso, et al.
The Journal of Biological Chemistry|March 4, 2000
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexesS Di Marco, M Rizzi, C Volpari, et al.
The Journal of Biological Chemistry|May 16, 2000
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transferD Fattori, A Urbani, M Brunetti, et al.
The EMBO Journal|March 16, 2000
Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domainG Barbato, D O Cicero, F Cordier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 6, 2006
Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymeraseC Giuliano, F Fiore, A Di Marco, et al.
Pageof 1